Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease

• Published in: Frontiers in molecular neuroscience Vol. 14; p. 821002
• Main Authors: Lan, Zhen, Chen, Yanting, Jin, Jiali, Xu, Yun, Zhu, Xiaolei
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 14-01-2022; Frontiers Media S.A
• Subjects: Alzheimer's disease; Amyloid; amyloid beta; Apoptosis; Brain; Chromosomes; Dementia; Dementia disorders; Enzymes; Gene expression; long non-coding RNA; Memory; Mitochondria; mitochondrial dysfunction; Molecular Neuroscience; Mutation; Neuroblastoma; Neurodegenerative diseases; Non-coding RNA; Oxidative stress; Pathogenesis; Phosphorylation; Proteins; RNA polymerase; tau phosphorylation; Tau protein; Therapeutic targets; synaptic dynamics; long non-coding RNA; mitochondrial dysfunction; biomarker; tau phosphorylation; Alzheimer's disease; amyloid beta; oxidative stress
• ISSN: 1662-5099; 1662-5099
• DOI: 10.3389/fnmol.2021.821002

Alzheimer's disease (AD), a heterogeneous neurodegenerative disorder, is the most common cause of dementia accounting for an estimated 60-80% of cases. The pathogenesis of AD remains unclear, and no curative treatment is available so far. Increasing evidence has revealed a vital role of non-coding RNAs (ncRNAs), especially long non-coding RNAs (lncRNAs), in AD. LncRNAs contribute to the pathogenesis of AD via modulating amyloid production, Tau hyperphosphorylation, mitochondrial dysfunction, oxidative stress, synaptic impairment and neuroinflammation. This review describes the biological functions and mechanisms of lncRNAs in AD, indicating that lncRNAs may provide potential therapeutic targets for the diagnosis and treatment of AD.